The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
Molecular Methods To Track Super-Resistant Gonorrhea
Scientists say that their new molecular approach will enhance the ability to track and contain the spread of drug-resistant gonorrhea.
More Work On HIV In Laos Needed
Though the incidence of HIV/AIDS in Laos is relatively low, more could be done to improve awareness and treatment coverage, say health officials.
Fruit Flies Help Uncover Tumor-Preventing Proteins
Scientists have identified a protein complex that stops brain cells from dedifferentiating back into stem cells, thereby preventing tumor formation.
India-Australia Collaboration To Develop Stress-Tolerant Rice
The US$546,800 joint project between India and Australia aims to develop a drought and salt-resistant rice strain by introducing Australian resurrection grass genes.
Timid Jumping Spider Uses Ant As Bodyguard
Ants act both as guardians and predators of jumping spiders in a three-species interaction described by scientists.
Migration In China: Shifting Slightly But Still Going Strong
A study of migration patterns in China over 25 years shows that while labor intensive jobs have been successfully created in the interior, educated workers are still leaving for the coastal cities.
Li Jingmei Awarded 2014 L’Oréal-UNESCO Fellowship
Already in it's 16th year, this year's UNESCO-L'Oréal award for women in science honors Singapore's Dr Li Jingmei among 14 other winners.
Study Shows HPV Vaccine Protects Against Cervical Cancer
By linking Queensland records of HPV vaccinations with the pap smear register, scientists have been able to show that vaccinations have been effective in protecting against cervical cancer.
Viva Biotech And HQL Pharmaceuticals Form Alliance
The alliance will combine Viva Biotech's expertise in fragment and structure based drug discovery and HQL Pharmaceutical's computational technology.